Valsartan And Hydrochlorothiazide
Product Images NDC 68258-6969

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Valsartan And Hydrochlorothiazide (NDC 68258-6969). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Dispensing Solutions, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Ndc 68258-6969-09 (Ndc 68258 6969 09 Lupin)

Ndc 68258-6969-09 (Ndc 68258 6969 09      Lupin)
This is a bulk source data provided by LUPIN Pharmaceuticals, Inc. The product identified is a yellow capsule-shaped film-coated biconvex tablet that is debossed with LU/P15. It is recommended to take one tablet orally once daily as directed by a doctor and not to discontinue without the doctor's advice. The tablet may cause drowsiness, dizziness, or headache. The product contains HYDROCHLOROTHIAZIDE USP and VALSARTAN/HCTZ 320mg/25mg, and it is dispensed in a tight/light-resistant container. The product is RX only and requires dispensing with patient information leaflet. The lot, sample expiration, RX# and other related information are included. The packaged is done exclusively by DISPENSING SOLUTIONS in Santa Ana, CA 92704.*
FDA Label Image

Image 1 (Valshctztabs Figure 01)

FDA Label Image

Image 2 (Valshctztabs Figure 02)

FDA Label Image

Image-3 (Valshctztabs Figure 03)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.